# CPMD (Cannapharmarx, Inc.) - SEC EDGAR Financial Statements

> Cannapharmarx, Inc. reported $1.18M in revenue and a net loss of $9.20M for the trailing twelve months ended September 30, 2026 (down 79.0% year over year), with a -130.7% gross margin and a -210.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/CPMD
- Markdown: https://convexityos.com/fundamentals/CPMD.md
- SEC CIK: 0001081938
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:13 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001081938&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $1.18M | -79.0% YoY |
| Operating Income | TTM | -$2.49M | -210.8% margin |
| Net Income | TTM | -$9.20M | -779.2% net margin |
| Diluted EPS | TTM | -$0.01 | Split-adjusted |
| Free Cash Flow | TTM | -$795K | -67.3% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $32K | Total debt: $5.77M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.36M | $820K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $3.45M | $3.76M | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | -$2.08M | -$2.93M | $0 | -- | -- | -- | -- | -- | -- | -- |
| Selling, General & Admin | -- | $117K | $704K | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | $1.26M | $696K | $1.58M | $5.21M | $2.99M | $14.49M | $15.98M | $954K | $6.6K | $1.00M |
| **Operating Income** | -$3.35M | -$3.63M | -$1.58M | -$5.21M | -$2.99M | -$14.49M | -$15.98M | -$954K | -$6.6K | -$1.00M |
| **EBITDA** | -- | -$3.63M | -$1.45M | -$4.92M | -$2.99M | -$14.36M | -$15.85M | -$954K | -$6.6K | -$1.00M |
| Interest Expense | $1.96M | $2.26M | $1.69M | $2.29M | $1.51M | $2.29M | $4.47M | $2.14M | $0 | $423 |
| Income Before Tax | -- | -- | -- | -$8.53M | -$8.83M | -$19.89M | -$20.45M | -$3.09M | -$6.6K | -$1.00M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$11.13M | -$9.91M | $3.69M | -$8.53M | -$8.83M | -$19.89M | -$20.45M | -$3.09M | -$6.6K | -$1.00M |
| Basic EPS | -- | -- | -- | $0.04 | $0.12 | -$0.49 | -$0.66 | -$0.17 | $0.00 | -$0.06 |
| **Diluted EPS** | -$0.02 | -$0.02 | $0.01 | $0.04 | $0.12 | -$0.49 | -$0.66 | -$0.17 | $0.00 | -$0.06 |
| Basic Shares Outstanding | -- | -- | -- | 211.0M | 74.7M | 40.7M | -- | -- | -- | -- |
| Diluted Shares Outstanding | 662.5M | 625.3M | 308.9M | 211.0M | 74.7M | 40.7M | 31.2M | 18.0M | 18.0M | 18.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $138K | $276K | $627K | $139K | $657K | $232K | $335K | $482K |
| Cost of Revenue | $415K | $415K | $1.04M | $856K | $1.03M | $853K | $838K | $2.17M |
| **Gross Profit** | -$278K | -$138K | -$409K | -$717K | -$374K | -$621K | -$503K | -$1.69M |
| Total Operating Expenses | $255K | $240K | $273K | $177K | $562K | $220K | $175K | -$163K |
| **Operating Income** | -$533K | -$379K | -$682K | -$894K | -$936K | -$841K | -$678K | -$1.53M |
| **EBITDA** | -- | -- | -$667K | -- | -$936K | -$841K | -$678K | -- |
| Interest Expense | $458K | $349K | $476K | $179K | $506K | $658K | $616K | $322K |
| Income Before Tax | $645K | -$1.91M | -- | -- | -$1.48M | -$1.41M | -- | -- |
| Income Tax Expense | $0 | $0 | -- | -- | $0 | $0 | -- | -- |
| **Net Income** | $645K | -$1.91M | -$382K | -$7.55M | -$1.48M | -$1.41M | -$691K | -$3.74M |
| Basic EPS | $0.00 | $0.00 | -- | -- | $0.00 | $0.00 | -- | -- |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| Basic Shares Outstanding | 708.7M | 682.5M | -- | -- | 662.5M | 662.5M | 662.5M | -- |
| Diluted Shares Outstanding | 1.27B | 682.5M | 669.8M | -- | 662.5M | 662.5M | 662.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.8K | $2.2K | $650 | $2.3K | $28K | $335K | $1.5K | $464K | $0 | $0 |
| **Cash & Short-Term Investments** | $1.8K | $2.2K | $650 | $2.3K | $28K | $335K | $1.5K | $464K | $0 | $0 |
| Accounts Receivable, Net | $164K | $1.7K | $0 | -- | -- | -- | -- | -- | -- | -- |
| Inventory | $1.12M | $996K | $1.13M | -- | -- | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | $5.9K | $0 | -- | -- | -- | -- | -- |
| **Total Current Assets** | $1.31M | $1.02M | $1.20M | $100K | $30K | $468K | $1.93M | $599K | $0 | $1.7K |
| Property, Plant & Equipment, Net | $127K | $137K | $162K | $108K | $6.0K | $1.57M | $1.54M | $1.69M | $0 | $0 |
| Goodwill | -- | -- | -- | -- | -- | $0 | $6.37M | $6.07M | -- | -- |
| Intangible Assets | -- | -- | -- | -- | -- | $0 | $1.83M | -- | -- | -- |
| **Total Non-Current Assets** | $5.71M | $9.82M | $10.55M | $5.31M | $85K | $8.28M | $14.09M | $9.50M | $0 | $0 |
| **Total Assets** | $7.02M | $10.84M | $11.75M | $5.41M | $114K | $8.75M | $16.02M | $10.10M | $0 | $1.7K |
| Accounts Payable | $10.06M | $4.78M | $4.93M | $6.88M | $3.13M | $3.58M | $903K | $766K | $605K | -- |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | $0 | -- | -- |
| Deferred Revenue (Current) | $261K | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Current Liabilities | $2.17M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $31.59M | $25.75M | $18.73M | $17.43M | $13.04M | $17.55M | $5.66M | $3.75M | $964K | $959K |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | $6.63M | -- | -- |
| **Total Non-Current Liabilities** | $5.58M | $4.89M | $5.17M | $5.33M | $0 | $0 | $5.50M | $6.63M | $0 | $0 |
| **Total Liabilities** | $37.17M | $30.65M | $23.90M | $22.76M | $13.04M | $17.55M | $11.16M | $10.38M | $964K | $959K |
| **Total Debt (incl. Leases)** | $6.03M | $5.62M | -- | -- | -- | -- | -- | $6.63M | -- | -- |
| Common Stock | $66K | $66K | $44K | $27K | $13K | $4.7K | $3.6K | $1.9K | $1.8K | $1.8K |
| Retained Earnings | -$112.3M | -$101.2M | -$91.28M | -$94.70M | -$86.16M | -$77.33M | -$57.44M | -$36.99M | -$33.90M | -$33.89M |
| Accumulated Other Comp. Income | -$57K | $556K | -$36K | $240K | -$372K | -$346K | $138K | $0 | -- | -- |
| **Total Stockholders' Equity** | -$30.15M | -$19.81M | -$12.15M | $17.34M | -$12.93M | -$8.80M | $4.85M | -$286K | -$964K | -$958K |
| Total Equity | -$30.15M | -$19.81M | -$12.15M | $17.34M | -$12.93M | -$8.80M | $4.85M | -$286K | -$964K | -$958K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $32K | $555 | $633 | $1.8K | $927 | $17K | $1.2K | $2.2K |
| **Cash & Short-Term Investments** | $32K | $555 | $633 | $1.8K | $927 | $17K | $1.2K | $2.2K |
| Accounts Receivable, Net | $0 | $6.8K | $6.9K | $164K | $588K | $114K | $263K | $1.7K |
| Inventory | $1.70M | $1.31M | $903K | $1.12M | $864K | $1.04M | $951K | $996K |
| **Total Current Assets** | $1.74M | $1.33M | $930K | $1.31M | $1.47M | $1.20M | $1.24M | $1.02M |
| Property, Plant & Equipment, Net | $195K | $200K | $176K | $127K | $123K | $129K | $130K | $137K |
| **Total Non-Current Assets** | $5.55M | $5.56M | $5.65M | $5.71M | $10.15M | $10.27M | $10.00M | $9.82M |
| **Total Assets** | $7.29M | $6.89M | $6.58M | $7.02M | $11.62M | $11.47M | $11.23M | $10.84M |
| Accounts Payable | $10.69M | $10.48M | -- | $10.06M | $5.61M | $5.46M | $5.07M | $4.78M |
| Deferred Revenue (Current) | $36K | $36K | $0 | $261K | -- | -- | $66K | $0 |
| Other Current Liabilities | $908K | -- | -- | $2.17M | -- | -- | -- | -- |
| **Total Current Liabilities** | $32.67M | $32.57M | $31.49M | $31.59M | $28.48M | $28.95M | $26.89M | $25.75M |
| **Total Non-Current Liabilities** | $4.81M | $5.15M | $5.36M | $5.58M | $5.65M | $5.09M | $4.85M | $4.89M |
| **Total Liabilities** | $37.47M | $37.72M | $36.85M | $37.17M | $34.13M | $34.05M | $31.74M | $30.65M |
| **Total Debt (incl. Leases)** | $5.77M | $5.78M | $5.91M | $6.03M | -- | -- | -- | $5.62M |
| Common Stock | $71K | $71K | $68K | $66K | $66K | $66K | $66K | $66K |
| Retained Earnings | -$114.0M | -$114.6M | -$112.7M | -$112.3M | -$104.8M | -$103.3M | -$101.9M | -$101.2M |
| Accumulated Other Comp. Income | $527K | $528K | $209K | -$57K | $174K | -$105K | $549K | $556K |
| **Total Stockholders' Equity** | -$30.19M | -$30.83M | -$30.27M | -$30.15M | -$22.52M | -$22.57M | -$20.51M | -$19.81M |
| Total Equity | -$30.19M | -$30.83M | -$30.27M | -$30.15M | -$22.52M | -$22.57M | -$20.51M | -$19.81M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$11.13M | -$9.91M | $3.69M | -$8.53M | -$8.83M | -$19.89M | -$20.45M | -$3.09M | -$6.6K | -$1.00M |
| Depreciation & Amortization | -- | $0 | $128K | $295K | $2.7K | $129K | $129K | $0 | $0 | $0 |
| Stock-Based Compensation | -- | -- | -- | $181K | $363K | $820K | $736K | $28K | $0 | $728K |
| Change in Receivables | -$1.01M | -$1.7K | $0 | -$22K | -$1.2K | $28K | $0 | -- | -- | -- |
| Change in Inventory | -$1.99M | -$508K | -$1.13M | -- | -- | -- | -- | -- | -- | -- |
| Change in Payables | $157K | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$789K | -$1.70M | -$2.27M | -$1.45M | -$2.41M | -$564K | -$3.79M | -$941K | $0 | -$22K |
| Capital Expenditure | -$5.5K | $0 | -$81K | -$116K | -$6.3K | $0 | -$4.8K | $0 | -- | $0 |
| **Free Cash Flow** | -$795K | -$1.70M | -$2.36M | -$1.56M | -$2.42M | -$564K | -$3.80M | -$941K | -- | -$22K |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | $0 | -$727K | $0 | -- |
| **Investing Cash Flow** | $794K | $1.70M | -$81K | -$116K | $494K | $0 | -$47K | -$727K | $0 | $0 |
| Common Stock Issued | -- | -- | -- | $290K | $291K | $0 | -- | -- | -- | $0 |
| Share Repurchases | -- | -- | -- | -- | -- | $0 | -$99K | $0 | -- | -- |
| **Financing Cash Flow** | -$5.5K | $0 | $2.35M | $1.40M | $1.34M | $825K | $3.27M | $2.13M | $0 | $20K |
| **Net Change in Cash** | -$352 | $1.5K | -$1.7K | -$25K | -$307K | $261K | -$575K | $464K | $0 | -$2.6K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $645K | -$1.91M | -$382K | -$7.55M | -$1.48M | -$1.41M | -$691K | -$3.74M |
| Depreciation & Amortization | -- | -- | $16K | -- | $0 | $0 | $0 | -- |
| Change in Receivables | -$2.8K | -$269K | -$359K | -$431K | -$479K | $160K | -$261K | $181K |
| Change in Inventory | -$526K | -$632K | -$281K | -$893K | -$90K | -$589K | -$416K | $108K |
| **Operating Cash Flow** | -$167K | -$127K | -$244K | $1.06M | -$803K | -$446K | -$601K | -$180K |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$180K |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $1.70M |
| **Financing Cash Flow** | $199K | $182K | $242K | -$1.85M | $787K | $462K | $600K | -$1.52M |
| **Net Change in Cash** | $31K | -$78 | -$1.2K | $877 | -$16K | $16K | -$948 | -$4.8K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -153.1% | -357.9% | -- | -- | -- | -- | -- | -- | -- | -- |
| **Operating Margin** | -245.8% | -442.7% | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -817.2% | -1207.8% | -- | -- | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | -- | -- | -49.2% | -- | -- | -421.3% | -- | -- | -- |
| Return on Assets (ROA) | -158.6% | -91.4% | 31.4% | -157.6% | -7725.4% | -227.4% | -127.7% | -30.6% | -- | -60063.0% |
| Current Ratio | 0.04x | 0.04x | 0.06x | 0.01x | 0.00x | 0.03x | 0.34x | 0.16x | 0.00x | 0.00x |
| Quick Ratio | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.02x | 0.00x | 0.12x | 0.00x | 0.00x |
| **Revenue Growth (YoY)** | +66.1% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -368.6% | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -66.7% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -130.7% | -96.4% | -128.2% | -162.6% | -186.9% | -232.9% | -240.9% | -323.8% |
| **Operating Margin** | -210.8% | -170.1% | -202.7% | -245.8% | -233.5% | -261.7% | -286.8% | -408.7% |
| **Net Profit Margin** | -779.2% | -666.2% | -654.2% | -817.2% | -429.3% | -415.5% | 99.1% | -1207.8% |
| Return on Assets (ROA) | -126.2% | -164.2% | -164.5% | -158.6% | -63.0% | -49.3% | 10.0% | -91.4% |
| Current Ratio | 0.05x | 0.04x | 0.03x | 0.04x | 0.05x | 0.04x | 0.05x | 0.04x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.01x | 0.02x | 0.01x | 0.01x | 0.00x |
| **Revenue Growth (YoY)** | -79.0% | +19.3% | +87.1% | -71.2% | +110.3% | -- | +1197.7% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -318.4% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -884.3% | -126.4% | -- | -149.6% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
